GNC Holdings Inc. (NYSE:GNC) was downgraded by equities research analysts at Vetr from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday. They presently have a $17.00 price target on the stock. Vetr‘s price objective suggests a potential upside of 10.39% from the company’s previous close.

Several other equities analysts have also issued reports on the stock. Piper Jaffray Cos. lowered shares of GNC Holdings from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $20.00 in a report on Thursday, July 28th. Barclays PLC started coverage on shares of GNC Holdings in a report on Friday, September 23rd. They issued an “equal weight” rating and a $21.00 price target on the stock. Zacks Investment Research raised shares of GNC Holdings from a “sell” rating to a “hold” rating in a report on Wednesday, September 28th. Bank of America Corp. downgraded shares of GNC Holdings from a “neutral” rating to an “underperform” rating and set a $13.00 price objective for the company. in a research note on Friday, October 28th. Finally, Wedbush downgraded shares of GNC Holdings from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $31.00 to $23.00 in a research note on Monday, August 1st. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $23.58.

Analyst Recommendations for GNC Holdings (NYSE:GNC)

Shares of GNC Holdings (NYSE:GNC) opened at 15.40 on Tuesday. The stock has a 50 day moving average price of $17.06 and a 200 day moving average price of $21.59. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of 5.86 and a beta of 0.83. GNC Holdings has a 1-year low of $12.78 and a 1-year high of $35.90.

GNC Holdings (NYSE:GNC) last released its quarterly earnings results on Thursday, October 27th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.71 by $0.12. GNC Holdings had a return on equity of 53.97% and a net margin of 7.35%. The firm earned $628 million during the quarter, compared to analysts’ expectations of $651.33 million. During the same period in the prior year, the firm posted $0.76 earnings per share. GNC Holdings’s revenue for the quarter was down 8.1% compared to the same quarter last year. Equities research analysts anticipate that GNC Holdings will post $2.47 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 30th. Stockholders of record on Friday, December 16th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Wednesday, December 14th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 5.19%. GNC Holdings’s dividend payout ratio is currently 30.30%.

Several hedge funds have recently added to or reduced their stakes in the company. Commerzbank Aktiengesellschaft FI bought a new stake in GNC Holdings during the second quarter worth approximately $387,000. Bank of New York Mellon Corp boosted its stake in shares of GNC Holdings by 0.8% in the second quarter. Bank of New York Mellon Corp now owns 950,658 shares of the company’s stock valued at $23,092,000 after buying an additional 7,420 shares in the last quarter. Emerald Advisers Inc. PA boosted its stake in shares of GNC Holdings by 58.0% in the second quarter. Emerald Advisers Inc. PA now owns 94,561 shares of the company’s stock valued at $2,297,000 after buying an additional 34,700 shares in the last quarter. Lucus Advisors LLC boosted its stake in shares of GNC Holdings by 85.7% in the second quarter. Lucus Advisors LLC now owns 14,138 shares of the company’s stock valued at $343,000 after buying an additional 6,525 shares in the last quarter. Finally, HealthInvest Partners AB boosted its stake in shares of GNC Holdings by 16.2% in the second quarter. HealthInvest Partners AB now owns 681,955 shares of the company’s stock valued at $16,565,000 after buying an additional 95,000 shares in the last quarter. 92.62% of the stock is owned by institutional investors and hedge funds.

WARNING: “GNC Holdings Inc. (GNC) Rating Lowered to Buy at Vetr Inc.” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be read at https://www.thecerbatgem.com/2016/11/24/gnc-holdings-inc-gnc-rating-lowered-to-buy-at-vetr-inc.html.

GNC Holdings Company Profile

GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products. The Company operates in three segments: Retail, Franchising and Manufacturing/Wholesale. The Retail segment includes sales of products to customers at its company-owned stores in the United States, Canada, Puerto Rico and Ireland and through its Websites, GNC.com and LuckyVitamin.com.

5 Day Chart for NYSE:GNC

Receive News & Stock Ratings for GNC Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC Holdings Inc. and related stocks with our FREE daily email newsletter.